Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Intrinsic Subtypes from the PAM50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort: Prognostication of Short- and Long-term Outcomes

Bette J. Caan, Carol Sweeney, Laurel A. Habel, Marilyn L. Kwan, Candyce H. Kroenke, Erin K. Weltzien, Charles P. Quesenberry Jr, Adrienne Castillo, Rachel E. Factor, Lawrence H. Kushi and Philip S. Bernard
Bette J. Caan
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol Sweeney
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurel A. Habel
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn L. Kwan
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Candyce H. Kroenke
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin K. Weltzien
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles P. Quesenberry Jr
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne Castillo
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel E. Factor
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence H. Kushi
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip S. Bernard
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-1017 Published May 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2014 to April 2021

AbstractFull-text HTMLPDF
Total343326874298

Cited By

Article Information

Volume 23, Issue 5, pp. 725-734

DOI 
https://doi.org/10.1158/1055-9965.EPI-13-1017
PubMed 
24521998

Published By 
American Association for Cancer Research
Print ISSN 
1055-9965
Online ISSN 
1538-7755
History 
  • Received October 7, 2013
  • Revision received January 16, 2014
  • Accepted January 16, 2014
  • Published first February 12, 2014.

Article Versions

  • Previous version (February 12, 2014 - 07:01).
  • Previous version (April 17, 2014 - 06:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2014 American Association for Cancer Research.

Author Information

  1. Bette J. Caan1,
  2. Carol Sweeney2,3,
  3. Laurel A. Habel1,
  4. Marilyn L. Kwan1,
  5. Candyce H. Kroenke1,
  6. Erin K. Weltzien1,
  7. Charles P. Quesenberry Jr1,
  8. Adrienne Castillo1,
  9. Rachel E. Factor3,4,
  10. Lawrence H. Kushi1, and
  11. Philip S. Bernard3,4
  1. Authors' Affiliations: 1Division of Research, Kaiser Permanente Northern California, Oakland, California; 2Department of Internal Medicine, Division of Epidemiology; 3Huntsman Cancer Institute, University of Utah; and 4The Associated Regional and University Pathologist Institute for Clinical and Experimental Pathology, Salt Lake City, Utah
  1. Corresponding Author:
    Bette J. Caan, Division of Research, Kasier Permanente, 2000 Broadway, Oakland, CA 94612. Phone: 510-891-3719; Fax: 510-891-3836; E-mail: bette.caan{at}kp.org
View Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (5)
May 2014
Volume 23, Issue 5
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Intrinsic Subtypes from the PAM50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort: Prognostication of Short- and Long-term Outcomes
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Intrinsic Subtypes from the PAM50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort: Prognostication of Short- and Long-term Outcomes
Bette J. Caan, Carol Sweeney, Laurel A. Habel, Marilyn L. Kwan, Candyce H. Kroenke, Erin K. Weltzien, Charles P. Quesenberry Jr, Adrienne Castillo, Rachel E. Factor, Lawrence H. Kushi and Philip S. Bernard
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 725-734; DOI: 10.1158/1055-9965.EPI-13-1017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intrinsic Subtypes from the PAM50 Gene Expression Assay in a Population-Based Breast Cancer Survivor Cohort: Prognostication of Short- and Long-term Outcomes
Bette J. Caan, Carol Sweeney, Laurel A. Habel, Marilyn L. Kwan, Candyce H. Kroenke, Erin K. Weltzien, Charles P. Quesenberry Jr, Adrienne Castillo, Rachel E. Factor, Lawrence H. Kushi and Philip S. Bernard
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 725-734; DOI: 10.1158/1055-9965.EPI-13-1017
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Disclaimer
    • Authors' Contributions
    • Grant Support
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Early-Life Risk Factors for Breast Cancer
  • Sugary Drink Consumption and Colorectal Cancer Risk
  • HPV Testing in Self-samples and Urine
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement